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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To a) summarise the evidence, b) identify gaps in the evidence base and c) describe elements of non-pharmacological, non-surgical
and non-device interventions for the management of COPD using a standardised taxonomy for disease management adapted from the
American Heart Association (Krumholz 2006).
B A C K G R O U N D
Description of the condition
Chronic obstructive pulmonary disease (COPD) is the fourth
most common cause of death internationally and accounts
for 3.5% of total years lost due to disability (World Health
Organisation 2004). This highly burdensome condition impacts
on 80 million people and their families globally. It is characterised
by non-reversible airflow limitation in conjunction with progres-
sive debilitating symptoms and systemic effects (Global Initiative
for COPD (GOLD) 2010). Increases in bio-fuel use and smoking,
particularly in developing countries, are set to increase the preva-
lence of COPD globally by 30% by 2030 (Buist 2007; Mannino
2002; World Health Organisation 2004).
Despite optimisation of pharmacological treatments such as in-
haled medications, a large proportion of individuals with COPD
continue to have inadequately managed symptoms and unmet
psychosocial needs (Bausewein 2008; Disler 2012; Effing 2007).
Comprehensive approaches to disease management that engage
“multiple therapies into a patient-centred plan of care” (Make
2003) are necessary to meet these healthcare needs (Craig 2008;
Make 2003; Monninkhof 2003).
Description of the interventions
Key non-pharmacological interventions such as pulmonary reha-
bilitation and self-management programmes are central to COPD
management and are highlighted in international COPD man-
agement guidelines (ATS/ERS 2011; Global Initiative for COPD
(GOLD) 2010; National Institute for Clinical Excellence 2012).
Chronic diseases such asCOPDrequire a comprehensive approach
to disease management (Make 2003), potentially incorporating a
range of diverse non-pharmacological, non-device and non-sur-
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gical intervention strategies. The intervention strategies discussed
in this overview, and defined below are: pulmonary rehabilitation;
self-management programs; action plans as an integrated strategy
andmanagement guideline; telehealthcare; and outreach programs
(ATS/ERS 2011; Bausewein 2008; Effing 2007; Global Initiative
for COPD (GOLD) 2010; Kruis 2011; Lacasse 2006;Make 2003;
McLean 2011; World Health Organisation 2004).
Pulmonary rehabilitation
Pulmonary rehabilitation focuses on building exercise capac-
ity, disease and nutritional education, and psychological coach-
ing. (ATS/ERS 2011; Celli 2004; Global Initiative for COPD
(GOLD) 2010; National Institute for Clinical Excellence 2012;
Nici 2006). Pulmonary rehabilitation is defined as “an evidence-
based, multidisciplinary, and comprehensive intervention for pa-
tients with chronic respiratory diseases who are symptomatic and
often have decreased daily life activities. Integrated into the in-
dividualized treatment of the patient, pulmonary rehabilitation
is designed to reduce symptoms, optimize functional status, in-
crease participation, and reduce health care costs through stabiliz-
ing or reversing systemic manifestations of the disease.”(ATS/ERS
2011).
Self-management programs
Self-management programs are defined as “any formalized patient
education programme aimed at teaching skills needed to carry out
medical regimens specific to the disease, guide health behaviour
change, and provide emotional support for patients to control
their disease and live functional lives” (Effing 2007). Patients with
COPD experience high symptom burden and poor health-related
quality of life, and are required to manage their condition over
extended periods (Bourbeau 2003). Evidence suggests that self-
management education programs that target skills to assist patients
in coping are likely to reduce hospital admissions in patients with
COPD, but there is heterogeneity in current studies (Effing 2007).
Action plans as part of an integrated strategy
and management guideline
Action plans are defined as “the use of guidelines which outline
self-initiated interventions (such as changing medication regime
or visiting the general practitioner or hospital) which are under-
taken appropriately in response to alterations in the state of the
patients’ COPD (e.g. increase in breathlessness, increased amount
or purulence of sputum) that suggest the commencement of an
exacerbation” (Turnock 2005). Patients who receive early inter-
vention for exacerbations of COPD symptoms are shown to re-
cover sooner and experience better quality of life with ongoing
optimal management (Wilkinson 2004). Action plans have been
shown to be effective in early intervention in asthmamanagement;
however the evidence for their efficacy in COPD has been limited
(Gallefoss 1999; Turnock 2005).
Telehealthcare
Telehealthcare is a rapidly expanding field in healthcare and
chronic disease management (Inglis 2010; McLean 2011). Tele-
healthcare in COPD is described by a recent Cochrane Review
as “using technology such as telephones, video cameras and the
Internet to allow people to stay at home and communicate with
a nurse or doctor when they have a period of increased breath-
lessness” (McLean 2011). Considering the housebound status of
people with advanced COPD and the frequency with which pa-
tients access acute health services as the disease progresses, tele-
healthcare has particular applicability in this population (McLean
2011). Telehealthcare has great potential in the resource-limited
future of modern health care.
Outreach programs
Outreach programs are those interventions that “comprise home
visits by a respiratory nurse or similar respiratory health worker,
to facilitate health care, provide education, provide social support,
identify respiratory deteriorations promptly and reinforce correct
technique with inhaler therapy” (Wong 2012). Delivery of care in
the community targets those patients who are housebound or fre-
quently reliant on acute services in the advanced stages of COPD.
Outreach programs strive tomaintain optimalmanagement of dis-
ease and assist patients in self-management behaviours, as well as
regular monitoring and early intervention in condition deteriora-
tion. A recent Cochrane systematic review found that this type of
intervention does improve health -elated quality of life; however
the current studies are heterogeneous in their approach (Wong
2012).
Why it is important to do this overview
Chronic diseases such as COPD require a comprehensive and
multi-dimensional approach to disease management that incorpo-
rates a range of integrated intervention components, for example
exercise rehabilitation with self-management education (Global
Initiative for COPD (GOLD) 2010; Make 2003; World Health
Organisation 2004).
Many of these discrete interventions are complex in both design
and delivery, and require distillation of essential elements: e.g. the
type, frequency and level of intervention intensity, as well as de-
scription of the workforce type and scope. Using a pre-specified
and standardised taxonomy may assist in providing information
to health providers and consumers in design of effective and ap-
propriate interventions for COPDmanagement (Krumholz 2006;
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Make 2003). Understanding the most efficacious organisation,
timing and sequencing of these interventionswithin a diseaseman-
agement approach, as well as resource requirements for these ap-
proaches, are of high interest internationally and will inform pol-
icy, healthcare decisions and future research (Disler 2012; Effing
2007; Krumholz 2006; Make 2003).
This overview will summarise evidence for non-pharmacologi-
cal, non-surgical, non-device programs for the management of
COPD, highlight the current gaps in knowledge, provide recom-
mendations for how best to report outcomes for these complex
interventions and inform future program improvement and de-
sign. Specifically, we will investigate the evidence for pulmonary
rehabilitation, self-management programs, action plans as part of
an integrated strategy and management guideline, telehealthcare
and outreach programs.
O B J E C T I V E S
To a) summarise the evidence, b) identify gaps in the evidence base
and c) describe elements of non-pharmacological, non-surgical
and non-device interventions for themanagement of COPDusing
a standardised taxonomy for disease management adapted from
the American Heart Association (Krumholz 2006).
M E T H O D S
Criteria for considering reviews for inclusion
Types of reviews
Wewill include reviews published in the Cochrane Database of Sys-
tematic Reviews (CDSR) that examine non-pharmacological, non-
surgical, or non-device strategies for the management of COPD.
This overview seeks to assess the evidence published in the original
Cochrane systematic reviews and will not seek to update these re-
views. However, specific information about intervention compo-
nents may be sought from trial reports and individual researchers.
Types of participants
People with a clinical diagnosis of COPD according to the defini-
tions in the original reviews.
Types of interventions
We will include non-pharmacological, non-surgical, non-device
intervention strategies for the management of COPD within
a comprehensive and multifaceted approach, specifically: pul-
monary rehabilitation; self-management programs; action plans
as an integrated strategy and management guideline; telehealth-
care; and outreach programs. We will exclude reviews of surgical
treatments and treatment devices as outside of the scope of this
overview, for example non-invasive ventilation, continuous posi-
tive airway pressure and lung volume reduction surgery will not
be included.
Types of outcome
The following outcomes will be discussed and reported if present
within the included Cochrane systematic reviews:
Primary outcomes
• Health-related quality of life (any validated measure)
• All cause hospital admissions
• All cause emergency department presentations
Secondary outcomes
• Patient-reported breathlessness (any validated measure)
• Functional capacity (any validated measure)
Search methods for identification of reviews
We will search the Cochrane Database of Systematic Reviews on
The Cochrane Library (latest issue) using the search strategy in
Appendix 1. We will not apply date or language restrictions. All
protocols for ongoing reviewswill be noted in the ’Studies awaiting
assessment’ section for possible inclusion in future updates of this
overview.
Data collection and analysis
Selection of reviews
Two authors (RTD, PMD) independently will assess Cochrane
systematic reviews as being ’for exclusion’, ’for inclusion’, or ’po-
tentially eligible’ on the basis of title and abstract. We will locate
full texts for Cochrane reviews judged as ’eligible’ or ’potentially
eligible’ and two independent authors (RTD, PMD) will judge
their suitability for inclusion against the inclusion criteria. In the
instance of disagreement a third review author will adjudicate.
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Data extraction and management
Two review authors (RTD, PMD) will independently extract data
from included Cochrane reviews and a third author will check all
extracted data for accuracy and consistency. We will collect ex-
tracted data using a customised electronic data extraction form.
The data extracted will include review objectives, participant in-
formation, primary outcome measurements and limitations noted
in the review. Quality of included reviews (using AMSTAR) and
quality of evidence in included reviews (using GRADE and risk of
bias) data will be extracted for assessment of overall methodolog-
ical quality. In addition, we will extract details of the following
elements for discussion: intervention content; delivery personnel;
method of communication; intensity and complexity of interven-
tion; setting and environment; and outcome measures (Krumholz
2006; Ryan 2011).
Dealing with missing data
Outcomes will be discussed and reported if present within the
included original Cochrane Systematic reviews. If any information
from the reviews is unclear or missing, we will access the published
reports of the individual trials and contact individual researchers.
Assessment of methodological quality of included
reviews
Quality of included reviews
Two review authors (RTD, PMD) will assess the methodological
quality of the included reviews independently using the ‘assess-
ment of multiple systematic reviews’ (AMSTAR) measurement
tool (Shea 2009). Disagreements will be resolved by a third author.
We will not exclude Cochrane reviews on the basis of method-
ological quality.
Quality of evidence in included reviews
Two review authors (RTD, PMD) will assess the quality of evi-
dence presented in the included reviews using the GRADE assess-
ment tool and through assessment of risk of bias of the included
evidence. We will retrospectively apply the risk of bias tool and
GRADE the evidence from trials in individual systematic review
where this was not done previously (Higgins 2011).
’Summary of findings’ tables
We plan to prepare several summary tables. Summary tables will
present data extracted on the characteristics of included reviews;
the methodological quality of included reviews (AMSTAR rat-
ings); the quality of evidence in included reviews (GRADEand risk
of bias); and a summary of primary outcomes reported in included
reviews - by intervention (pulmonary rehabilitation, self-manage-
ment programs, action plans as part of an integrated approach,
telehealthcare, and outreach programs). We will summarise in-
formation on the multi-component interventions used in COPD
disease management using an adapted standardised disease man-
agement taxonomy. This ’elements of multi-component interven-
tions’ table will include the following content: intervention con-
tent, delivery personnel, method of communication, intensity and
complexity of intervention, setting and environment, and out-
come measures (Krumholz 2006).
Data synthesis
We do not anticipate that we will be able to perform quantitative
data analyses. Therefore we will present a narrative summary of
results for the individual reviews and primary outcomes. For future
updates of this overview wemay performquantitative data analysis
of interventions across reviews for the primary outcomes if data
permit.
We will present narrative descriptions of the evidence for
non-pharmacological, non-surgical, non-device interventions for
COPD using two comparisons: intervention versus placebo, and
intervention A versus intervention B (e.g. self-management versus
standard care or self-management versus action plans). This de-
scriptive approach to summarising evidence is similar to the suc-
cessful approaches seen in the Cochrane overviews of pain man-
agement for women in labour (Jones 2012) and of consumer-ori-
ented interventions for evidence-based prescribing and medicines
use (Ryan 2011).
We plan to adapt and apply a standardised disease management
taxonomy to organise the discussion (Table 1). We hope that the
use of such a framework will guide discussion and increase the
utility of the review for decision-makers by promoting increased
understanding of intervention intensity and duration and work-
force requirements (Krumholz 2006).
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A P P E N D I C E S
Appendix 1. Search strategy: The Cochrane Library
#1 MeSH descriptor Pulmonary Disease, Chronic Obstructive explode all trees
#2 MeSH descriptor Lung Diseases, Obstructive, this term only
#3 COPD:ti
#4 (obstruct*) near/3 (pulmonary or lung* or airway* or airflow* or bronch* or respirat*):ti
#5 (#1 OR #2 OR #3 OR #4)
[Limited to Cochrane Database of Systematic Reviews]
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